J.W. Cole Advisors Inc. Sells 540 Shares of SPDR S&P Biotech ETF (NYSEARCA:XBI)

J.W. Cole Advisors Inc. lessened its holdings in shares of SPDR S&P Biotech ETF (NYSEARCA:XBI) by 1.5% in the third quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The institutional investor owned 35,744 shares of the exchange traded fund’s stock after selling 540 shares during the quarter. J.W. Cole Advisors Inc.’s holdings in SPDR S&P Biotech ETF were worth $3,532,000 as of its most recent filing with the Securities & Exchange Commission.

Other institutional investors and hedge funds also recently added to or reduced their stakes in the company. ORG Partners LLC purchased a new position in shares of SPDR S&P Biotech ETF during the 2nd quarter worth approximately $40,000. ORG Wealth Partners LLC bought a new stake in shares of SPDR S&P Biotech ETF during the third quarter valued at approximately $44,000. Waldron Private Wealth LLC purchased a new stake in SPDR S&P Biotech ETF in the third quarter worth $54,000. Resources Management Corp CT ADV raised its holdings in SPDR S&P Biotech ETF by 30.3% in the second quarter. Resources Management Corp CT ADV now owns 593 shares of the exchange traded fund’s stock worth $55,000 after purchasing an additional 138 shares in the last quarter. Finally, Lynx Investment Advisory purchased a new stake in shares of SPDR S&P Biotech ETF in the 2nd quarter worth about $58,000.

SPDR S&P Biotech ETF Stock Performance

Shares of XBI opened at $97.15 on Monday. The firm’s 50-day simple moving average is $99.14 and its two-hundred day simple moving average is $94.65. SPDR S&P Biotech ETF has a fifty-two week low of $63.80 and a fifty-two week high of $103.52. The stock has a market cap of $7.40 billion, a PE ratio of 11.47 and a beta of 1.11.

SPDR S&P Biotech ETF Company Profile

SPDR S&P Biotech ETF (the Fund) seeks to closely match the returns and characteristics of the S&P Biotechnology Select Industry Index. The S&P Biotechnology Select Industry Index represents the biotechnology sub-industry portion of the S&P Total Markets Index. The S&P TMI tracks all the United States common stocks listed on the New York Stock Exchange, American Stock Exchange, National Association of Securities Dealers Automated Quotation (NASDAQ) National Market and NASDAQ Small Cap exchanges.